⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
AARD News
Aardvark Therapeutics, Inc. Common Stock
Join Class Action to Recover Losses from Aardvark Therapeutics, Inc. (AARD) - Contact Levi & Korsinsky Before October 13, 2026
accessnewswire.com
AARD
AARD Investors Have Opportunity to Lead Aardvark Therapeutics, Inc. Securities Fraud Lawsuit with SBS Law
globenewswire.com
AARD
AARD UPCOMING DEADLINE: SueWallSt Alerts Aardvark Therapeutics, Inc. Stockholders of Securities Class Action - Contact the Firm
prnewswire.com
AARD
Pomerantz Law Firm Announces the Filing of a Class Action Against Aardvark Therapeutics, Inc. and Certain Officers and Directors - AARD
prnewswire.com
AARD
Levi & Korsinsky Urges Aardvark Therapeutics, Inc. (AARD) Shareholders to Act Before Lead Plaintiff Deadline October 13, 2026
accessnewswire.com
AARD
AARD LAWSUIT ALERT: Levi & Korsinsky Notifies Aardvark Therapeutics, Inc. Investors - Lead Plaintiff Deadline October 13, 2026
accessnewswire.com
AARD
Join Class Action to Recover Losses from Aardvark Therapeutics, Inc. (AARD) - Contact Levi & Korsinsky Before October 13, 2026
accessnewswire.com
AARD
AARDVARK THERAPEUTICS (NASDAQ: AARD) SECURITIES CLASS ACTION: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Investors With Losses in Excess of $100K to Secure Counsel Before Important October 13 Deadline
accessnewswire.com
AARD
Class Action Initiated by Pomerantz LLP Against Aardvark Therapeutics, Inc. – AARD
accessnewswire.com
AARD
Bragar Eagel & Squire, P.C. Urges Aardvark Therapeutics, Inc. Investors to Contact the Firm Seeking Lead Plaintiff Role Before October 13th
globenewswire.com
AARD